Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action

Por Navarro, Maribel, Castro, William, Madamet, Marilyn, Amalvict, Rémy, Benoit, Nicolas, Pradines, Bruno
Publicado no Malar J (2014)

Pleuromutilins: Potent Drugs for Resistant Bugs—Mode of Action and Resistance

Por Paukner, Susanne, Riedl, Rosemarie
Publicado no Cold Spring Harb Perspect Med (2017)

Disease-modifying drugs in Alzheimer’s disease

Por Ghezzi, Laura, Scarpini, Elio, Galimberti, Daniela
Publicado em 2013

Drug discovery and development for neglected diseases: the DNDi model

Por Chatelain, Eric, Ioset, Jean-Robert
Publicado em 2011

Current and emerging drugs for the treatment of inflammatory bowel disease

Por Triantafillidis, John K, Merikas, Emmanuel, Georgopoulos, Filippos
Publicado em 2011

Resveratrol as a potential therapeutic drug for respiratory system diseases

Por Zhu, Xiao-dan, Lei, Xiao-ping, Dong, Wen-bin
Publicado no Drug Des Devel Ther (2017)

Translational challenges of animal models in Chagas disease drug development: a review

Por Chatelain, Eric, Konar, Nandini
Publicado no Drug Des Devel Ther (2015)

Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases

Por Allarakhia, Minna
Publicado em 2013

Combination of drugs and carriers in drug delivery technology and its development

Por Du, Ying, Chen, Baoan
Publicado no Drug Des Devel Ther (2019)

Mode of action of thiocoraline, a natural marine compound with anti-tumour activity

Por Erba, E, Bergamaschi, D, Ronzoni, S, Faretta, M, Taverna, S, Bonfanti, M, Catapano, C V, Faircloth, G, Jimeno, J, D'Incalci, M
Publicado em 1999

Identification of novel drug targets in bovine respiratory disease: an essential step in applying...

Por Sakharkar, Meena Kishore, Rajamanickam, Karthic, Chandra, Ramesh, Khan, Haseeb A, Alhomida, Abdullah S, Yang, Jian
Publicado no Drug Des Devel Ther (2018)

Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair

Por Lisowska, Barbara, Kosson, Dariusz, Domaracka, Karolina
Publicado no Drug Des Devel Ther (2018)

Exploring prospects of novel drugs for tuberculosis

Por Janssen, Saskia, Jayachandran, Rajesh, Khathi, Lulama, Zinsstag, Jakob, Grobusch, Martin P, Pieters, Jean
Publicado em 2012

Leishmaniasis in humans: drug or vaccine therapy?

Por Ghorbani, Masoud, Farhoudi, Ramin
Publicado no Drug Des Devel Ther (2017)

Synthetic biology for pharmaceutical drug discovery

Por Trosset, Jean-Yves, Carbonell, Pablo
Publicado no Drug Des Devel Ther (2015)

Paclitaxel: new uses for an old drug

Por Zhang, Dongshan, Yang, Ruhao, Wang, Shixuan, Dong, Zheng
Publicado em 2014

Route of Drug Abuse and its Impact on Oral Health-Related Quality of Life among Drug Addicts

Por Sharma, Aditi, Singh, Simarpreet, Mathur, Anmol, Aggarwal, Vikram Pal, Gupta, Neha, Makkar, Diljot Kaur, Batra, Manu, Gijwani, Deeksha
Publicado no Addict Health (2018)

Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae

Por Dean, Charles R., Barkan, David T., Bermingham, Alun, Blais, Johanne, Casey, Fergal, Casarez, Anthony, Colvin, Richard, Fuller, John, Jones, Adriana K., Li, Cindy, Lopez, Sara, Metzger, Louis E., Mostafavi, Mina, Prathapam, Ramadevi, Rasper, Dita, Reck, Folkert, Ruzin, Alexey, Shaul, Jacob, Shen, Xiaoyu, Simmons, Robert L., Skewes-Cox, Peter, Takeoka, Kenneth T., Tamrakar, Pramila, Uehara, Tsuyoshi, Wei, Jun-Rong
Publicado no Antimicrob Agents Chemother (2018)

Amino Acid-Derived 1,2-Benzisothiazolinone Derivatives as Novel Small-Molecule Antifungal Inhibitors: Identification of Potential Genetic Targets

Por Alex, Deepu, Gay-Andrieu, Francoise, May, Jared, Thampi, Linta, Dou, Dengfeng, Mooney, Aileen, Groutas, William, Calderone, Richard
Publicado em 2012

Organelle targeting: third level of drug targeting

Por Sakhrani, Niraj M, Padh, Harish
Publicado em 2013